摘要
目的探讨婴幼儿动脉导管未闭合并肺动脉高压介入封堵治疗临床效果。方法对30例动脉导管未闭合并肺动脉高压婴幼儿进行介入封堵,年龄最小4个月,最大27个月,平均(10.0±3.5)个月。体质量最小3.5 kg,最大12 kg,平均(7.0±2.5)kg。动脉导管未闭最窄处直径最小3.5 mm,最大12 mm,平均(5.5±2.3)mm。肺动脉收缩压最大98 mm Hg(1 mm Hg=0.133 k Pa),最小40 mm Hg,平均(65.0±5.7)mm Hg。结果 30例中29例封堵成功(96.7%),无死亡患者。结论婴幼儿动脉导管未闭合并肺动脉高压需尽早治疗,介入封堵术是一种安全有效的治疗方式,可作为该类疾病的首选治疗方案。
Objectives To evaluate the safety and efficacy of percutaneous closure of patent ductus arteriosus （PDA） and pulmonary hypertension （PH） in infants. Methods Totally 30 infants underwent percutaneous closure of PDA. Their average age at the time of procedure was （10±3.5） months （range 4 to 27 months） and the average weight was （7.0±2.5） kg （range 3.5 to 12 kg）. The average diameter of PDA was （5.5±2.3） mm （range 3.5 to 12 ram） and the average pulmonary arterial systolic pressure was （65.0±5.7） mm Hg （range 40 to 98 mm Hg） （1 mm Hg=0.133 kPa）. Results Twenty-nine （96.7%） of the 30 cases were occluded successfully and no dead case occurred. Conclusions PDA and PH in infants should be treated in early period. Percutaneous closure is safe and effective that can be the first option for treatment.
出处
《岭南心血管病杂志》
2015年第6期839-841,共3页
South China Journal of Cardiovascular Diseases
关键词
动脉导管未闭
婴幼儿
肺动脉高压
介入封堵
patent duetus arteriosus
infant
pulmonary hypertension
percutaneous closure
